The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in hep G2 cells
- 234 Downloads
The development of macromolecules as drugs and drug carriers requires knowledge of their fate in cells. To this end, we studied the internalization and subcellular fate of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers in Hep G2 (human hepatocellular carcinoma) cells. Semiquantitative fluorometry confirmed that galactose was an effective ligand for receptor-mediated endocytosis for Hep G2 cells. The rate of internalization of a galactose-targeted copolymer was almost 2 orders of magnitude larger than that of the nontargeted copolymer. Confocal fluorescent microscopy of both fixed and live cells revealed that the polymer entered the cells by endocytosis. After longer incubation times (typically >8 hours), polymer escaped from small vesicles and distributed throughout the cytoplasm and nuclei of the cells. Polymer that entered the cytoplasm tended to accumulate in the nucleus. Microinjection of the HPMA copolymers into cells' cytoplasm and nuclei indicated that the polymers partitioned to the nucleus. The data from fixed cells was confirmed by microscopy of live, viable cells. To examine the effect of the fluorescent dye on the intracellular fate, polymers with fluorescein, Oregon Green 488, Lissamine rhodamine B, and doxorubicin were tested; no significant differences were observed.
KeyWordsHPMA copolymer subcellular trafficking endocytosis microinjection confocal fluorescent microscopy
Unable to display preview. Download preview PDF.
- 13.Tomlinson E, Hirota S, Lee VHL, Pouton CW. Advanced Drug Delivery Reviews: Challenges of Turning Nucleic Acids into Therapeutics. Vol. 44. New York: Elsevier Science, 2000: 79–208.Google Scholar
- 14.Duncan R, Lee VHL. Journal of Drug Tergeting: Special Issue on Gene Delivery and Targeting. Vol. 7. Berkshire, UK: Harwood Academic Publishers. 1999: 241–324.Google Scholar
- 16.Wroblewski S, Berenson M, Kopečková P, Kopeček J. Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. J Biomed Mater Res. 2000; 51: 329–342.PubMedCrossRefGoogle Scholar
- 22.Knowles BB, Aden DP. Human hepatoma derived cell line, process for preparation thereof, and uses therefore. U.S. Patent 4,393, 133, July 12, 1983.Google Scholar
- 26.Brelje TC. Confocal Assistant. 4.02 ed, Copyright 1994–1996.Google Scholar
- 36.Seymour LW, Duncan R, Strohalm J, Kopeček J. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res. 1987; 21: 1341–1358.PubMedCrossRefGoogle Scholar
- 37.Cartlidge SA, Duncan R, Lloyd JB, Kopečková-Rejmanová P, Kopeček J. Soluble crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers. 2. Effect of molecular weight on blood clearance and body distribution in the rat after intravenous administration. Distribution of unfractionated copolymer after intraperitoneal, subcutaneous or oral administration. J Control Release. 1987; 4: 253–264.CrossRefGoogle Scholar
- 41.Hovorka O, Ulbrich K, Strohalm J, Davoust J, Říhová B. Visualization of the effect of targeted drugs. Paper presented at: 24th International Symposium on Controlled Release of Bioactive Materials; June 1997; Stockholm, Sweden.Google Scholar
- 42.Nori A, Jensen KD, Kopečková P, Kopeček J. Cytoplasmic delivery and nuclear targeting of HPMA copolymer-TAT conjugates to human ovarian carcinoma cells. Paper presented at: 28th International Symposium on Controlled Release of Bioactive Materials: June 2001; San Diego, CA.Google Scholar
- 43.Šubr V, Strohalm J, Ulbrich K, Duncan R, Hume IC. Polymers containing enzymatically degradable bonds, xii. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [n-(2-hydroxypropyl)-methacrylamide] copolymer drug carriers in vitro and antitumour activity measured in vivo. J Control Release. 1992; 18: 123–132.CrossRefGoogle Scholar